1. Home
  2. CVGI vs SCYX Comparison

CVGI vs SCYX Comparison

Compare CVGI & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVGI
  • SCYX
  • Stock Information
  • Founded
  • CVGI 2000
  • SCYX 1999
  • Country
  • CVGI United States
  • SCYX United States
  • Employees
  • CVGI N/A
  • SCYX N/A
  • Industry
  • CVGI Auto Parts:O.E.M.
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVGI Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • CVGI Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • CVGI 34.0M
  • SCYX 28.5M
  • IPO Year
  • CVGI 2004
  • SCYX 2014
  • Fundamental
  • Price
  • CVGI $1.97
  • SCYX $0.73
  • Analyst Decision
  • CVGI Buy
  • SCYX
  • Analyst Count
  • CVGI 1
  • SCYX 0
  • Target Price
  • CVGI $10.00
  • SCYX N/A
  • AVG Volume (30 Days)
  • CVGI 578.0K
  • SCYX 114.5K
  • Earning Date
  • CVGI 08-04-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • CVGI N/A
  • SCYX N/A
  • EPS Growth
  • CVGI N/A
  • SCYX N/A
  • EPS
  • CVGI N/A
  • SCYX N/A
  • Revenue
  • CVGI $698,524,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • CVGI N/A
  • SCYX $463.61
  • Revenue Next Year
  • CVGI $7.37
  • SCYX $310.80
  • P/E Ratio
  • CVGI N/A
  • SCYX N/A
  • Revenue Growth
  • CVGI N/A
  • SCYX N/A
  • 52 Week Low
  • CVGI $0.81
  • SCYX $0.66
  • 52 Week High
  • CVGI $5.69
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • CVGI 78.36
  • SCYX 41.87
  • Support Level
  • CVGI $1.25
  • SCYX $0.66
  • Resistance Level
  • CVGI $1.41
  • SCYX $0.78
  • Average True Range (ATR)
  • CVGI 0.13
  • SCYX 0.05
  • MACD
  • CVGI 0.07
  • SCYX -0.00
  • Stochastic Oscillator
  • CVGI 95.57
  • SCYX 37.37

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: